Venture Certified
| 벤처투자유형 | 2022-06-08 ~ 2025-06-07 | 20220609010028 | 2022-06-08 |
| 벤처투자유형 | 2025-06-08 ~ 2028-06-07 | 20250507010047 | 2022-06-08 |
Revenue CAGR +277.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 14B | 6.1B | 1.0B |
| Operating Profit | -3.2B | -6.5B | -4.9B |
| Net Profit | -0.5B | -2.4B | -3.5B |
| Total Assets | 5.0B | 3.9B | 5.1B |
| Total Liabilities | 5.0B | 3.3B | 2.8B |
| Total Equity | 0.0B | 0.6B | 2.4B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Debt Ratio 10680.0%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -3B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+10121pp YoY)
▲ 288.8%
▲ 43.9%
▲ 92.5%
▲ 3053.5%
▼ 326.2%
| Name | Position | Role |
|---|---|---|
| 김영현 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경북 포항시",
"ceo_name": "김영현",
"certificate": [
{
"cert_number": "20220609010028",
"changes": "",
"disclosure_date": "2022-06-09",
"first_cert_date": "2022-06-08",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2022-06-08 ~ 2025-06-07"
},
{
"cert_number": "20250507010047",
"changes": "",
"disclosure_date": "2025-05-07",
"first_cert_date": "2022-06-08",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2025-06-08 ~ 2028-06-07"
}
],
"company_name": "(주)헤세드바이오",
"corp_no": "171711-*******",
"financials": {
"2022": {
"capital_stock": 76148000,
"cost_of_sales": 92003000,
"current_assets": 388108000,
"current_liabilities": 279249000,
"gross_profit": 3835000,
"net_income": -345491000,
"net_income_bs": -345491000,
"non_current_assets": 126247000,
"non_current_liabilities": 0,
"non_operating_expenses": 21259000,
"non_operating_income": 170767000,
"operating_profit": -494999000,
"revenue": 95838000,
"sga_expenses": 498833000,
"total_assets": 514355000,
"total_equity": 235106000,
"total_liabilities": 279249000
},
"2023": {
"capital_stock": 77016000,
"cost_of_sales": 237178000,
"current_assets": 289428000,
"current_liabilities": 331345000,
"gross_profit": 369918000,
"net_income": -240760000,
"net_income_bs": -240759000,
"non_current_assets": 101238000,
"non_current_liabilities": 0,
"non_operating_expenses": 18053000,
"non_operating_income": 426914000,
"operating_profit": -649621000,
"revenue": 607095000,
"sga_expenses": 1019538000,
"total_assets": 390666000,
"total_equity": 59321000,
"total_liabilities": 331345000
},
"2024": {
"capital_stock": 77016000,
"cost_of_sales": 280050000,
"current_assets": 211164000,
"current_liabilities": 495659000,
"gross_profit": 1086401000,
"net_income": -54679000,
"net_income_bs": -54680000,
"non_current_assets": 289137000,
"non_current_liabilities": 0,
"non_operating_expenses": 17293000,
"non_operating_income": 283718000,
"operating_profit": -321104000,
"revenue": 1366451000,
"sga_expenses": 1407505000,
"total_assets": 500301000,
"total_equity": 4641000,
"total_liabilities": 495659000
}
},
"industry": "기타 인문 및 사회과학 연구개발업",
"investment": [
{
"amount": "499,000,000",
"changes": "499,000,000",
"date": "2022-03-21"
},
{
"amount": "499,987,293",
"changes": "499,987,293",
"date": "2022-03-21"
}
],
"main_products": "연구개발(화장품, 건강기능식품, 항생제,대사질환신약)",
"phone": "070-8844-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |